Babcock International Group PLC
10 July 2026
10 July 2026
Babcock International Group PLC
BABCOCK INTERNATIONAL GROUP PLC £250 million BOND ISSUE
Babcock International Group ('the Group' or 'Babcock') announces the issue of £250 million of five-year bonds carrying fixed coupon of 5.125%, the Group's first bond issue for seven years, to refinance the £300 million bond maturing in October 2026.
Babcock's strong proposition, fundamentals and balance sheet, combined with leading market positioning in defence and nuclear, has led to a high level of demand, allowing us to price on attractive terms.
The net proceeds of the issue will be used for general corporate purposes, including ongoing investment to support and drive growth.
BABCOCK ANNOUNCES PUBLICATION OF FINAL TERMS
The final terms dated 10 July 2026 (the "Final Terms") relating to the issue by Babcock on 14 July 2026 of GBP 250,000,000 5.125% per cent notes due 2026 (the "Notes") have been submitted to the UK Listing Authority and are available for viewing.
The Notes have been issued pursuant to the base prospectus dated 3 March 2026 (the "Base Prospectus") relating to the £3,000,000,000 Euro Medium Term Note Programme (the "Programme") of Babcock.
To view the full document, please paste the following URL into the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/9659L_1-2026-7-10.pdf
A copy of the Final Terms has been submitted to the National Storage Mechanism and will be available at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
For further information please contact:
|
Andrew Gollan |
Samuel MacGregor |
|
Director of Investor Relations |
Investor Relations Manager |
|
Tel: (0)7936 039004 |
Tel: (0)7730 753159 |
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain whether or not you are part of the intended addressees of the information contained therein.
In particular, the Prospectus does not constitute an offer of securities for sale in the United States. This is not for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any state or other jurisdiction of the United States and securities in bearer form are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered, sold or (in the case of securities in bearer form) delivered within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States.
Your right to access this service is conditional upon complying with the above requirement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.